Inventor

RYU JE HO

KR11 patents

⚠️ This page may combine multiple inventors who share the name “RYU JE HO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SK CHEMICALS CO LTD

4 patents

US7495022B2Feb 24, 2009

α,β-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors

SK CHEMICALS CO LTD14 citations82

US7601736B2Oct 13, 2009

Pyridine derivatives, a process for their preparation and a pharmaceutical composition containing the same

SK CHEMICALS CO LTD2 citations59

US7442714B2Oct 28, 2008

Amlodipine gentisate and a method of its preparation

SK CHEMICALS CO LTD0 citations45

US9643946B2May 9, 2017

Tricyclic compound and use thereof

SK CHEMICALS CO LTD0 citations36

SAMSUNG ELECTRONICS CO LTD

2 patents

US10816802B2Oct 27, 2020

Transparent display apparatus, method for controlling the same, and computer-readable recording medium

SAMSUNG ELECTRONICS CO LTD0 citations48

US10540922B2Jan 21, 2020

Transparent display apparatus and display method thereof

SAMSUNG ELECTRONICS CO LTD0 citations37

IN2GEN CO LTD

1 patent

US6962911B2Nov 8, 2005

Pyrrolopyrimidinone derivatives, process of preparation and use

IN2GEN CO LTD3 citations58

RYU JE HO

1 patent

US9096571B2Aug 4, 2015

Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and pharmaceutical composition comprising the same

RYU JE HO2 citations53

UBIX THERAPEUTICS INC

1 patent

US12122763B2Oct 22, 2024

Substituted piperidines for androgen receptor degradation

UBIX THERAPEUTICS INC1 citations47

LEE JU YOUNG

1 patent

US10155763B2Dec 18, 2018

2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors

LEE JU YOUNG1 citations47

KOREA RES INST CHEMICAL TECH

1 patent

US12161722B2Dec 10, 2024

Bifunctional heterocyclic compound having BTK degradation function via ubiquitin proteasome pathway, and use thereof

KOREA RES INST CHEMICAL TECH0 citations44